Evaluation of the efficacy and safety of levetiracetam treatment for neonatal seizures in extremely preterm infants
Aim: Levetiracetam (LEV) is increasingly being used to treat seizures in the neonatal period. Data about using LEV in extremely preterm infants with seizures is insufficient and limited with only a handful studies. This study aimed to evaluate the efficacy and safety of LEV in the treatment of seizu...
Main Authors: | Leman Tekin Orgun, Mustafa Kurthan Mert |
---|---|
Format: | Article |
Language: | English |
Published: |
Journal of Surgery and Medicine
2020-05-01
|
Series: | Journal of Surgery and Medicine |
Subjects: | |
Online Access: | https://dergipark.org.tr/en/pub/josam/issue/54145/724986 |
Similar Items
-
Efficacy of levetiracetam for neonatal seizures in preterm infants
by: Ji Yoon Han, et al.
Published: (2018-04-01) -
Pharmacokinetics of levetiracetam in neonates with seizures
by: Merhar, Stephanie L., M.D.
Published: (2011) -
Etiologies of neonatal seizures in infants of different gestational age
by: A. N. Zavadenko, et al.
Published: (2018-11-01) -
Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
by: Jae Won Shin, et al.
Published: (2017-02-01) -
Levetiracetam as the First-line Antiepileptic in Neonatal Seizures
by: Hari Prasath Ramachandran, et al.
Published: (2020-10-01)